The incidence rate of cervical cancer in Korea is still higher than in other developed
countries, notwithstanding the national mass-screening program. Furthermore, a new …

Evidence-based clinical guidelines ensure best practice protocols are available in health
care. There is a widespread use of human papillomavirus deoxyribonucleic acid (HPV-DNA) …

This study investigated the distribution of HPV types in Korean women and evaluated the
carcinogenic risk of individual HPV types and the potential effects of HPV vaccines. A total of …

Objectives To evaluate the long‐term outcomes and risk factors for recurrence after fertility‐
sparing laparoscopic radical trachelectomy (LRT) in young women with early‐stage cervical …

Eradication of cervical cancer involves the expansion of human papillomavirus (HPV)
vaccine coverage and the development of efficient screening guidelines that take …

Detecting high-risk (HR) HPV is important for clinical management of women with persistent
HPV-positive and Pap-negative results. The Cobas 4800 HPV test is the first FDA-approved …

This study aimed to provide basic data for the clinical application of urine samples to prevent
cervical cancer due to persistent HR-HPV infection in women who refuse invasive cervical …

Current ASCCP guidelines recommend repeat cytology 12 months after HPV‐positive
results in women aged 21–24 years with either atypical squamous cells of undetermined …

The clinical performance of three human papillomavirus (HPV) DNA commercial assays for
cervical cancer screening was evaluated; the AdvanSure HPV Screening Real-Time PCR …

Background: Despite the increasing number of screening examinations performed for
cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined …